Application of add-on-design in post-marketing evaluation of traditional Chinese medicine.
10.19540/j.cnki.cjcmm.20210201.503
- Author:
Zhong-Qi YANG
1
;
Hui-Min TANG
1
;
Yan-Ping DU
1
;
Ya-Qin TANG
1
;
Tian-Hui YUAN
1
;
Zhi-Fei WANG
2
;
Yan-Ming XIE
2
Author Information
1. the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407, China.
2. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
add-on-design;
post-marketing evaluation;
traditional Chinese medicine
- MeSH:
Drugs, Chinese Herbal;
Humans;
Marketing;
Medicine, Chinese Traditional;
Quality Control;
Quality of Life
- From:
China Journal of Chinese Materia Medica
2021;46(8):1994-1998
- CountryChina
- Language:Chinese
-
Abstract:
Post-marketing evaluation of traditional Chinese medicine(TCM) is an important research stage in the life cycle of a drug, and the add-on-design is a common method for its post-marketing evaluation. This article introduces the basic concept of add-on-design, and points out that it is suitable for use based on the principles of medical ethics when the standard treatment should not be interrupted. The post-marketing evaluation of TCM should be carried out based on human experience and in compliance with regulations and ethics. The clinical values of TCM, such as the therapeutic effect for disease, improvement of disease symptoms, improvement in quality of life, as well as the synergism and toxicity attenuation of combined use of TCM and chemical drugs, should be fully reflected through the clinical trials designed with add-on-design. The key points of add-on-design are accurate clinical positioning, scientific estimation of sample size, and rigorous standard treatment. Standard treatment should be a recognized one, consistent and stable; appropriate and recognized efficacy indicators and targeted safety indicators should be selected; the design and operation of clinical research scheme should meet the requirements of randomization and blind method, with special emphasis on the production of qualified placebo. The add-on-design has the advantages that the rights and interests of the subjects are adequately protected. Besides, the research conclusions are easily put into clinical application. But there are also many difficulties, such as the influence of confounding bias, the "ceiling" effect of clinical efficacy, and the difficulty of interpretation of adverse events. Therefore, a rigorous research quality assu-rance system should be established, and the quality control of evaluation consistency of researchers should be emphasized to ensure strict quality control in the research process.
